(Q37162734)

English

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study

scientific article published on 19 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

1

object named as

Adrian Covic

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

object named as

Adrian Ghenu

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jutta Passlick-Deetjen

2

object named as

Jutta Passlick-Deetjen

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Miroslaw Kroczak

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Beatrix Büschges-Seraphin

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Pedro Ponce

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Barbara Marzell

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Angel L M de Francisco

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

19 June 2013

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

28

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2383-2392

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

6 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Effects of phosphate binders in moderate CKD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Hypomagnesaemia, the kidney and the vessels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Calcium deficiency reduces circulating levels of FGF23.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

FGF23 and PTH--double agents at the heart of CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

What would we like to know, and what do we not know about fibroblast growth factor 23?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

New insights into the role of fibroblast growth factor 23 in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Magnesium in chronic kidney disease: challenges and opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

FGF23-parathyroid interaction: implications in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Serum phosphate levels and risk of infection in incident dialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to the renal response against acidosis in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

6 September 2017

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

14 September 2017

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

27 June 2018

FGF23 beyond mineral metabolism: a bridge to cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

3 September 2018

Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

20 October 2018

Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769980

20 October 2018

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physicochemical effects of acidosis on bone calcium flux and surface ion composition

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NDT/GFT203

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

release_sa7pj3hfvvbzfbnog5j6svubvi

1 reference

https://api.fatcat.wiki/v0/release/sa7pj3hfvvbzfbnog5j6svubvi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37162734&oldid=1864545075"